Skip to main content
Top
Published in: BMC Medicine 1/2020

01-12-2020 | Public Health | Opinion

Rapid publications risk the integrity of science in the era of COVID-19

Authors: N. Bagdasarian, G. B. Cross, D. Fisher

Published in: BMC Medicine | Issue 1/2020

Login to get access

Abstract

Background

Preprint manuscripts, rapid publications and opinion pieces have been essential in permitting the lay press and public health authorities to preview data relating to coronavirus disease 2019 (COVID-19), including the range of clinical manifestations and the basic epidemiology early on in the pandemic. However, the rapid dissemination of information has highlighted some issues with communication of scientific results and opinions in this time of heightened sensitivity and global concern.

Main text

Rapid publication of COVID-19 literature through expedited review, preprint publications and opinion pieces are important resources for the medical scientific community. Yet the risks of unverified information loom large in times when the healthcare community is desperate for information. Information that has not been properly vetted, or opinion pieces without solid evidence, may be used to influence public health policy decisions. We discuss three examples of unverified information and the consequences in this time of high anxiety surrounding COVID-19.

Conclusions

In an era when information can be widely and swiftly disseminated, it is important to ensure that the scientific community is not an inadvertent source of misinformation. This will require a multimodal approach, with buy-in from editors, publishers, preprint servers, authors and journalists. The landscape of medical publications has changed, and a collaborative approach is required to maintain a high standard of scientific communications.
Literature
1.
go back to reference Rubin EJ, Baden LR, Morrissey S, Campion EW. Medical journals and the 2019-nCoV outbreak. N Engl J Med. 2020;382(9):866.CrossRef Rubin EJ, Baden LR, Morrissey S, Campion EW. Medical journals and the 2019-nCoV outbreak. N Engl J Med. 2020;382(9):866.CrossRef
2.
go back to reference Jarvis C. Journals, peer reviewers cope with surge in COVID-19 publications. In: The Scientist; 2020. Jarvis C. Journals, peer reviewers cope with surge in COVID-19 publications. In: The Scientist; 2020.
3.
go back to reference Science has an ugly, complicated dark side. And the coronavirus is bringing it out. 2020. Science has an ugly, complicated dark side. And the coronavirus is bringing it out. 2020.
4.
go back to reference Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–1.CrossRef Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–1.CrossRef
5.
go back to reference Mary E, Wilson M. Asymptomatic 2019-nCoV transmission in Germany, and first U.S. case described; 2020. Mary E, Wilson M. Asymptomatic 2019-nCoV transmission in Germany, and first U.S. case described; 2020.
8.
go back to reference Twitter W: Asymptomatic #2019nCoV infection may be rare. In: Asymptomatic #2019nCoV infection may be rare, and transmission from an asymptomatic person is very rare with other coronaviruses, as we have seen with MERS Thus, transmission from asymptomatic cases is likely not a major driver of transmission. Twitter; 2020. https://twitter.com/who/status/1223659708072038400?lang=en. Accessed 13 May 2020. Twitter W: Asymptomatic #2019nCoV infection may be rare. In: Asymptomatic #2019nCoV infection may be rare, and transmission from an asymptomatic person is very rare with other coronaviruses, as we have seen with MERS Thus, transmission from asymptomatic cases is likely not a major driver of transmission. Twitter; 2020. https://​twitter.​com/​who/​status/​1223659708072038​400?​lang=​en. Accessed 13 May 2020.
10.
go back to reference Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020.
11.
go back to reference Parodi SM, The Permanente Medical Group KP, Oakland, California, The Permanente Federation O, California, Liu VX, The Permanente Medical Group KP, Oakland, California, Kaiser Permanente Division of Research O, California: From containment to mitigation of COVID-19 in the US. JAMA 2020. Parodi SM, The Permanente Medical Group KP, Oakland, California, The Permanente Federation O, California, Liu VX, The Permanente Medical Group KP, Oakland, California, Kaiser Permanente Division of Research O, California: From containment to mitigation of COVID-19 in the US. JAMA 2020.
12.
go back to reference Lauer SA, Johns Hopkins Bloomberg School of Public Health B, Maryland (S.A.L., K.H.G., Q.B., F.K.J., Q.Z., H.R.M., A.S.A., J.L.), Grantz KH, Johns Hopkins Bloomberg School of Public Health B, Maryland (S.A.L., K.H.G., Q.B., F.K.J., Q.Z., H.R.M., A.S.A., J.L.), Bi Q, Johns Hopkins Bloomberg School of Public Health B, Maryland (S.A.L., K.H.G., Q.B., F.K.J., Q.Z., H.R.M., A.S.A., J.L.), Jones FK, Johns Hopkins Bloomberg School of Public Health B, Maryland (S.A.L., K.H.G., Q.B., F.K.J., Q.Z., H.R.M., A.S.A., J.L.), Zheng Q, Johns Hopkins Bloomberg School of Public Health B, Maryland (S.A.L., K.H.G., Q.B., F.K.J., Q.Z., H.R.M., A.S.A., J.L.) et al: The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Int Med. 2020. Lauer SA, Johns Hopkins Bloomberg School of Public Health B, Maryland (S.A.L., K.H.G., Q.B., F.K.J., Q.Z., H.R.M., A.S.A., J.L.), Grantz KH, Johns Hopkins Bloomberg School of Public Health B, Maryland (S.A.L., K.H.G., Q.B., F.K.J., Q.Z., H.R.M., A.S.A., J.L.), Bi Q, Johns Hopkins Bloomberg School of Public Health B, Maryland (S.A.L., K.H.G., Q.B., F.K.J., Q.Z., H.R.M., A.S.A., J.L.), Jones FK, Johns Hopkins Bloomberg School of Public Health B, Maryland (S.A.L., K.H.G., Q.B., F.K.J., Q.Z., H.R.M., A.S.A., J.L.), Zheng Q, Johns Hopkins Bloomberg School of Public Health B, Maryland (S.A.L., K.H.G., Q.B., F.K.J., Q.Z., H.R.M., A.S.A., J.L.) et al: The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Int Med. 2020.
13.
go back to reference Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, Liu L, Shan H, Lei C-l, Hui DS et al: Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv 2020:2020.2002.2006.20020974. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, Liu L, Shan H, Lei C-l, Hui DS et al: Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv 2020:2020.2002.2006.20020974.
16.
go back to reference Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-Q, He J-x, Liu L, Shan H, Lei C-l, Hui DSC et al: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-Q, He J-x, Liu L, Shan H, Lei C-l, Hui DSC et al: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020.
17.
go back to reference Fang L, Pulmonary Cell Research and Pneumology DoBaIM, University Hospital Basel, CH-4031 Basel, Switzerland, Karakiulakis G, Department of Pharmacology SoM, Aristotle University of Thessaloniki, Thessaloniki, Greece, Roth M, michael.roth@usb.ch, Pulmonary Cell Research and Pneumology DoBaIM, University Hospital Basel, CH-4031 Basel, Switzerland: Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):E21. https://doi.org/10.1016/S2213-2600(20)30116-8. Fang L, Pulmonary Cell Research and Pneumology DoBaIM, University Hospital Basel, CH-4031 Basel, Switzerland, Karakiulakis G, Department of Pharmacology SoM, Aristotle University of Thessaloniki, Thessaloniki, Greece, Roth M, michael.​roth@usb.​ch, Pulmonary Cell Research and Pneumology DoBaIM, University Hospital Basel, CH-4031 Basel, Switzerland: Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):E21. https://​doi.​org/​10.​1016/​S2213-2600(20)30116-8.
19.
go back to reference Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020.
20.
go back to reference Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD: Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD: Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020.
21.
go back to reference Veran O: #COVIDー19 | La prise d’anti-inflammatoires (ibuprofène, cortisone, ...) pourrait être un facteur d’aggravation de l’infection. En cas de fièvre, prenez du paracétamol. Si vous êtes déjà sous anti-inflammatoires ou en cas de doute, demandez conseil à votre médecin. In.. Veran O: #COVIDー19 | La prise d’anti-inflammatoires (ibuprofène, cortisone, ...) pourrait être un facteur d’aggravation de l’infection. En cas de fièvre, prenez du paracétamol. Si vous êtes déjà sous anti-inflammatoires ou en cas de doute, demandez conseil à votre médecin. In..
22.
go back to reference Sports MdlSed: Inscription et gestion de votre compte - Liste de diffusion DGS-Urgent. 2020. Sports MdlSed: Inscription et gestion de votre compte - Liste de diffusion DGS-Urgent. 2020.
23.
go back to reference Howley EK. Do anti-inflammatories like ibuprofen aggravate coronavirus? Here’s the research. In: US News and World Report, @USNews; 2020. Howley EK. Do anti-inflammatories like ibuprofen aggravate coronavirus? Here’s the research. In: US News and World Report, @USNews; 2020.
24.
go back to reference twitter W: Based on currently available information, WHO does not recommend against the use of of ibuprofen. 2020. twitter W: Based on currently available information, WHO does not recommend against the use of of ibuprofen. 2020.
27.
go back to reference Hypertension ISo: A statement from the International Society of Hypertension on COVID-19 | The International Society of Hypertension. 2020. Hypertension ISo: A statement from the International Society of Hypertension on COVID-19 | The International Society of Hypertension. 2020.
28.
go back to reference Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angi. 2020. Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angi. 2020.
30.
go back to reference ECDC: European Centre for Disease Prevention and Control. Social media strategy development – a guide to using social media for public health communication. Stockholm: ECDC; 2016. 2016. ECDC: European Centre for Disease Prevention and Control. Social media strategy development – a guide to using social media for public health communication. Stockholm: ECDC; 2016. 2016.
31.
go back to reference Communicating during an outbreak or public health investigation | Epidemic Intelligence Service | CDC; 2019. Communicating during an outbreak or public health investigation | Epidemic Intelligence Service | CDC; 2019.
33.
go back to reference Getting the word out. Nature Neuroscience. 2020, 12(3):235–235. Getting the word out. Nature Neuroscience. 2020, 12(3):235–235.
Metadata
Title
Rapid publications risk the integrity of science in the era of COVID-19
Authors
N. Bagdasarian
G. B. Cross
D. Fisher
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2020
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-020-01650-6

Other articles of this Issue 1/2020

BMC Medicine 1/2020 Go to the issue